Literature DB >> 15155978

Molecular epidemiology of malaria in cameroon. XX. Experimental studies on various factors of in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum.

Leonardo K Basco1.   

Abstract

The influence of several factors on parasite growth and 50% inhibitory concentration (IC(50)) for chloroquine was assessed. Most isolates stored at 4 degrees C up to 72 hours grew when they were subsequently cultivated. However, parasite viability sharply decreased from 24 hours, and the mean chloroquine IC(50) decreased significantly (P < 0.05). There was no evidence for selection of pre-culture populations due to storage alone. The time point when (3)H-hypoxanthine was added (0 versus 18 hours) had no effect on the IC(50) during the 42-hour incubation, but was associated with a lower IC(50) when (3)H-hypoxanthine was added after the initial 42-hour incubation during the 72-hour incubation. An increase in 3H-hypoxanthine incorporation and chloroquine IC(50) was observed as the hematocrit was increased from 1.0% to 2.5%. For the same isolates, chloroquine IC(50) values were generally similar when the initial parasitemia was between 0.1% and 0.5% but increased at higher (>0.75%) parasitemias. Based on these results, we recommend immediate cultivation after blood collection, a 42-hour incubation period with the addition of (3)H-hypoxanthine at the beginning of incubation, a 1.5% hematocrit, and an initial parasitemia 0.1-0.5%. Further studies on serum substitutes, gas mixture, and comparison of isotopic and non-isotopic assays are needed to establish a standardized in vitro assay protocol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155978

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  15 in total

1.  Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.

Authors:  David J Bacon; Christine Latour; Carmen Lucas; Olga Colina; Pascal Ringwald; Stéphane Picot
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

2.  Shelf life of predosed plates containing mefloquine, artemisinin, dihydroartemisinin, and artesunate as used for in vitro Plasmodium falciparum susceptibility assessment.

Authors:  Sandrine Houzé; Aline Munier; Xavier Paoletti; Halima Kaddouri; Pascal Ringwald; Jacques Le Bras
Journal:  J Clin Microbiol       Date:  2007-06-06       Impact factor: 5.948

3.  Phenotypic and genotypic analysis of in vitro-selected artemisinin-resistant progeny of Plasmodium falciparum.

Authors:  Matthew S Tucker; Tina Mutka; Kansas Sparks; Janus Patel; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

Review 4.  In vitro selection of Plasmodium falciparum drug-resistant parasite lines.

Authors:  Alexis Nzila; Leah Mwai
Journal:  J Antimicrob Chemother       Date:  2009-12-18       Impact factor: 5.790

5.  Monitoring antimalarial drug efficacy: current challenges.

Authors:  Miriam K Laufer
Journal:  Curr Infect Dis Rep       Date:  2009-01       Impact factor: 3.725

6.  Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs.

Authors:  Aurélie Pascual; Leonardo K Basco; Eric Baret; Rémy Amalvict; Dominique Travers; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2011-01-14       Impact factor: 2.979

Review 7.  Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.

Authors:  Jane Achan; Ambrose O Talisuna; Annette Erhart; Adoke Yeka; James K Tibenderana; Frederick N Baliraine; Philip J Rosenthal; Umberto D'Alessandro
Journal:  Malar J       Date:  2011-05-24       Impact factor: 2.979

8.  Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay.

Authors:  Sébastien Briolant; Philippe Parola; Thierry Fusaï; Marilyn Madamet-Torrentino; Eric Baret; Joël Mosnier; Jean P Delmont; Daniel Parzy; Philippe Minodier; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2007-04-16       Impact factor: 2.979

9.  Synthesis of New 4-Aminoquinolines and Evaluation of Their In Vitro Activity against Chloroquine-Sensitive and Chloroquine-Resistant Plasmodium falciparum.

Authors:  Chandima S K Rajapakse; Maryna Lisai; Christiane Deregnaucourt; Véronique Sinou; Christine Latour; Dipankar Roy; Joseph Schrével; Roberto A Sánchez-Delgado
Journal:  PLoS One       Date:  2015-10-16       Impact factor: 3.240

10.  World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibility.

Authors:  David J Bacon; Ronan Jambou; Thierry Fandeur; Jacques Le Bras; Chansuda Wongsrichanalai; Mark M Fukuda; Pascal Ringwald; Carol Hopkins Sibley; Dennis E Kyle
Journal:  Malar J       Date:  2007-09-06       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.